EUVIMEDEUVIMED entdecken
Qualitative StudieOpen Access · CC BY-NC 4.0

Improving imiquimod use in cervical high‐grade squamous intraepithelial lesions: A qualitative study

Caroline L P Muntinga iD, Helena C J Schellekens, Charlotte G J Penders, Hélène van Meir, Gatske M Nieuwenhuyzen-De Boer, Anna J M van de Sande, Heleen J van Beekhuizen iD, Peggy J de Vos Van Steenwijk, Ruud L M Bekkers, Edith M G van Esch

Acta Obstetricia et Gynecologica Scandinavica · 2025

DOI: 10.1111/aogs.70004 ↗

Kurz gefasst

Qualitative Studie in der Zeitschrift Acta Obstetricia et Gynecologica Scandinavica, 2025. Verfasst von Caroline L P Muntinga und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and Obstetrics, Catharina Ziekenhuis Eindhoven, Eindhoven, The Netherlands. Hauptthemen laut MEDLINE: Aminoquinolines, Antineoplastic Agents, Uterine Cervical Neoplasms, Squamous Intraepithelial Lesions of the Cervix. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

To investigate patient experiences and satisfaction with imiquimod for cervical high‐grade squamous intraepithelial lesions and its side effects, possibly influencing the (dis)continuation of treatment. Secondary objectives include evaluating patient counseling and guidance before and during imiquimod treatment for cervical high‐grade squamous intraepithelial lesions by gynecologists and nurse practitioners to improve patient guidance. Material and Methods Semi‐structured interviews were conducted with patients treated with imiquimod for cervical high‐grade squamous intraepithelial lesions and with healthcare professionals from hospitals in the Netherlands. Interviews were transcribed and transcripts were analyzed using thematic analysis.

Results

A total of 15 patients, 11 of whom finished imiquimod treatment and four who discontinued imiquimod treatment, and six healthcare professionals were interviewed. Three main themes were identified: counseling and side effects, use of imiquimod, and contact moments during treatment. Many patients believed that sharing patient experiences would help in making treatment decisions. Patients discontinued treatment early due to side effects and the mode of application. Detailed information on application methods and side effect severity during counseling is desirable. Healthcare professionals agreed on the factors that need to be addressed during counseling but held different opinions on imiquimod's side effect severity and application methods.

Conclusions

Adequate patient counseling on imiquimod treatment, including the possible application methods and potential side effects, along with optimal guidance during treatment, contributes to a better patient experience and reduces the likelihood of early discontinuation of treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AminoquinolinesAntineoplastic AgentsUterine Cervical NeoplasmsSquamous Intraepithelial Lesions of the CervixHumansImiquimodFemaleAdultQualitative ResearchMiddle AgedPatient SatisfactionNetherlandsInterviews as TopicCounseling

Stichwörter der Autor:innen

human papillomavirus virusesimiquimodlesions of the cervixsquamous intraepithelial lesions of the cervixuterine cervical dysplasia

Substanzen

ImiquimodAminoquinolinesAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Gynecology and Obstetrics, Catharina Ziekenhuis Eindhoven, Eindhoven, The Netherlands.
  • GROW-School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.
  • Department of Gynecology and Obstetrics, Maastricht Universitair Medisch Centrum, Maastricht, The Netherlands.
  • Department of Gynecology and Obstetrics, Tergooi Medisch Centrum, Hilversum, The Netherlands.
  • Department of Gynecology and Obstetrics, Albert Schweitzer Ziekenhuis, Dordrecht, The Netherlands.
  • Department of Gynecologic Oncology, Erasmus MC Cancer Center, University Medical Center, Rotterdam, The Netherlands.

ORCID-Profile: Caroline L P Muntinga, Heleen J van Beekhuizen

Zitieren

APA

Muntinga, C. L. P., Schellekens, H. C. J., Penders, C. G. J., van Meir, H., Nieuwenhuyzen-De Boer, G. M., van de Sande, A. J. M., van Beekhuizen, H. J., de Vos Van Steenwijk, P. J., Bekkers, R. L. M., & van Esch, E. M. G. (2025). Improving imiquimod use in cervical high‐grade squamous intraepithelial lesions: A qualitative study. Acta Obstetricia et Gynecologica Scandinavica. https://doi.org/10.1111/aogs.70004

Vancouver

Muntinga CLP, Schellekens HCJ, Penders CGJ, van Meir H, Nieuwenhuyzen-De Boer GM, van de Sande AJM, et al. Improving imiquimod use in cervical high‐grade squamous intraepithelial lesions: A qualitative study. Acta Obstetricia et Gynecologica Scandinavica. 2025. doi:10.1111/aogs.70004

BibTeX
@article{Muntinga2025,
  author = {Muntinga, Caroline L P and Schellekens, Helena C J and Penders, Charlotte G J and van Meir, Hélène and Nieuwenhuyzen-De Boer, Gatske M and van de Sande, Anna J M and van Beekhuizen, Heleen J and de Vos Van Steenwijk, Peggy J and Bekkers, Ruud L M and van Esch, Edith M G},
  title = {Improving imiquimod use in cervical high‐grade squamous intraepithelial lesions: A qualitative study},
  journal = {Acta Obstetricia et Gynecologica Scandinavica},
  year = {2025},
  doi = {10.1111/aogs.70004}
}
Kostenlos starten →